Omeros (OMER) Earnings Date & Reports

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

OMER is expected to report earnings to rise 2.31% to -55 cents per share on August 06

Q2'25

Est.

$-0.55

Q4'24

Beat

by $0.15

Q3'24

Beat

by $0.13

Q2'24

Missed

by $0.27

Q1'24

Missed

by $0.07

The last earnings report on March 31 showed earnings per share of -54 cents, beating the estimate of -68 cents. With 423.36K shares outstanding, the current market capitalization sits at 393.67M.

View a ticker or compare two or three

Compare

OMER